Compassionate use programmes allow the use of unauthorised or unlicensed medicines for patients for which there are no licensed treatments available, and who are unable to enter a clinical trial. They are intended to allow patients access new treatment options that are still under development. Your doctor will be able to advise you more specifically if this is an option available to you. Access to medicines via compassionate use programmes usually ends once the medicine receives a product licence.
The Medicines and Healthcare Regulatory Agency (MHRA) provides guidance on the compassionate use of medicines in the UK: